Franchitto Nicolas, Rolland Benjamin, Pelissier Fanny, Simon Nicolas
Department of Addiction Medicine, Toulouse-Purpan University Hospital, Toulouse, France.
Poison Control Center, Toulouse-Purpan University Hospital, Toulouse, France.
Front Psychiatry. 2018 Sep 4;9:417. doi: 10.3389/fpsyt.2018.00417. eCollection 2018.
Specialists in addiction medicine continue to debate whether baclofen is still indicated to treat alcohol use disorders in view of conflicting results as to its efficacy. This review summarizes current knowledge on self-poisoning with baclofen focusing of alcohol-use disorder in order to provide an overview of the reliable scientific knowledge on management of such an intoxication. Moreover, as alcohol-dependent patients experience many psychiatric co-morbidities, the risk in suicide attempt using baclofen seems real. Numerous studies have suggested that patients given daily-doses of baclofen higher than 80 mg/day are more likely to attempt suicides than others. Following an ingestion of a large amount of baclofen, central nervous system depression is usually observed. Seizures require the patient to be admitted in intensive care unit and should be treated like other toxicological seizures. Cardiac complications include prolonged QTc interval, degree heart block, premature atrial contractions, and supraventricular tachycardia, hypotension and bradycardia. In cases of intoxication, the elimination half-life of baclofen may last between 12 and 36 h post-overdose and renal failure is known to delay its clearance. Rarely measured in clinical practice, the toxic level of baclofen blood level ranges from 1.1 to 3.5 mg/l, and coma or fatal intoxication are observed from 6 to 9.6 mg/l. Baclofen withdrawal has been observed but making the diagnosis of withdrawal in case of suspected self-poisoning is difficult as baclofen intoxication and baclofen withdrawal share many clinical signs. Admission to hospital to manage of suicide attempt with baclofen is mandatory and should not be limited to baclofen alone. It needs to include other aspects of the overall care of patients with alcohol disorders (psychological and psychosocial interventions, management of comorbid mental conditions and physical complications).
鉴于巴氯芬治疗酒精使用障碍的疗效存在相互矛盾的结果,成瘾医学专家仍在争论该药是否仍适用于此类治疗。本综述总结了目前关于巴氯芬中毒(尤其是针对酒精使用障碍)的知识,以便概述关于此类中毒管理的可靠科学知识。此外,由于酒精依赖患者常伴有多种精神疾病,使用巴氯芬自杀的风险似乎确实存在。大量研究表明,每日服用巴氯芬剂量高于80毫克的患者比其他人更易出现自杀企图。大量摄入巴氯芬后,通常会出现中枢神经系统抑制。癫痫发作需将患者收入重症监护病房,并应像治疗其他毒理学癫痫发作一样进行处理。心脏并发症包括QTc间期延长、一度房室传导阻滞、房性早搏和室上性心动过速、低血压和心动过缓。中毒时,巴氯芬的消除半衰期在过量服药后可能持续12至36小时,已知肾衰竭会延迟其清除。巴氯芬血药浓度在临床实践中很少测定,中毒水平范围为1.1至3.5毫克/升,血药浓度达到6至9.6毫克/升时会出现昏迷或致命中毒。已观察到巴氯芬戒断情况,但在疑似中毒病例中诊断戒断很困难,因为巴氯芬中毒和巴氯芬戒断有许多共同的临床体征。因服用巴氯芬自杀企图而入院治疗是必要的,且不应仅限于巴氯芬本身。还需要包括酒精障碍患者整体护理的其他方面(心理和社会心理干预、合并精神疾病和身体并发症的管理)。